# The Medicines (Products for Human Use) (Fees) Regulations 2016, Paragraph 10: Office-based inspections


The fee for an inspection comprising an office-based evaluation and risk assessment of documentation but not involving inspection of a site, in connection with the monitoring of—
(a) good manufacturing practice, good clinical practice or good pharmacovigilance practice, is £4,924 per day;
(b) good distribution practice, is £3,810 per day.

---
Source: https://www.legislation.gov.uk/uksi/2016/190/schedule/3/paragraph/10 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/schedule-3/paragraph-10
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

